The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Regulation of DNA Binding of p53 by its C-terminal Domain
Abstract
The tumor suppressor p53 is a tetrameric multi-domain transcription factor. Its C-terminal domain is thought to regulate the binding of its core domain to specific recognition sequences in promoters. The mechanism of regulation by the C-terminal domain and the role of its post-translational modification are controversial. We have examined the binding of DNA in solution to a series of unmodified p53 constructs that lack various domains. The specific DNA sequences bind tightly to the core domain, irrespective of whether or not the C-terminal domain is part of the construct. Unmodified p53 is accordingly an active DNA binding protein. Non-specific DNA sequences do not inhibit directly the binding of the specific sequences to the core but bind to the C terminus and inhibit p53 via that binding mode. Using NMR, we identified the residues of the C terminus that interact with the non-specific DNA. They include residues that are known to be modified post-translationally. Our data provide direct support for the regulatory role of the C terminus in the activity of p53 and show that p53 containing the unmodified C terminus actively binds to short double-stranded DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two regions of the CTD, spanning residues 369-374 and 381-388 and with high lysine content, make dynamic and sequence-independent interactions with DNA in regions that flank the p53 recognition element.”
From Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR (2022) · cites this paper as [23]
In the citing paper
“The CTD can undergo disorder-to-order transitions as a result of binding to protein interactors or nonspecific DNA (Rustandi et al. 2000;Weinberg et al. 2004).”
From Structural Evolution and Dynamics of the p53 Proteins (2017) · cites this paper as Weinberg et al. 2004
In the citing paper
“Interaction of the p53 CTD with no specific DNA sequences regulates binding of the core domain to specific recognition sequences in promoters (Weinberg et al. 2004).”
From Structural Evolution and Dynamics of the p53 Proteins (2017) · cites this paper as Weinberg et al. 2004
In the citing paper
“The CTD is highly basic and binds non-specifically to DNA both as an isolated peptide and within the full-length p53 tetramer.23”
From Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR (2022) · cites this paper as [23]
Citations
Cites
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Research works printed but not linked: 40
- Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- Zhao, 2000, Analysis of p53-regulated gene expression patterns using oligonucleotide arrays, Genes Dev., 14, 981, 10.1101/gad.14.8.981 · DOI · Paper page
- Vousden, 2002, Live or let die: the cell's response to p53, Nature Rev. Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
- Fields, 1990, Presence of a potent transcription activating sequence in the p53 protein, Science, 249, 1046, 10.1126/science.2144363 · DOI · Paper page
- Walker, 1996, Identification of a novel p53 functinal domain that is necessary for efficient growth suppression, Proc. Natl Acad. Sci. USA, 93, 15335, 10.1073/pnas.93.26.15335 · DOI · Paper page
- Oliner, 1993, Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53, Nature, 362, 857, 10.1038/362857a0 · DOI · Paper page
- Thut, 1995, p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60, Science, 267, 100, 10.1126/science.7809597 · DOI · Paper page
- Lu, 1995, Human TAFII3 protein is a transcriptional co-activator of the p53 protein, Proc. Natl Acad. Sci. USA, 92, 5154, 10.1073/pnas.92.11.5154 · DOI · Paper page
- Bargonetti, 1993, A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein, Genes Dev., 7, 2565, 10.1101/gad.7.12b.2565 · DOI · Paper page
- Jeffrey, 1995, Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7angstroms, Science, 267, 1498, 10.1126/science.7878469 · DOI · Paper page
- Clore, 1995, Refined solution structure of the oligomerization domain of the tumour suppressor p53, Nature Struct. Biol., 2, 321, 10.1038/nsb0495-321 · DOI · Paper page
- Clore, 1994, High-resolution structure of the oligomerization domain of p53 by multidimensional NMR, Science, 265, 386, 10.1126/science.8023159 · DOI · Paper page
- Yakovleva, 2002, p53 latency—out of the blind alley, Trends Biochem. Sci., 27, 612, 10.1016/S0968-0004(02)02209-0 · DOI
- Ahn, 2001, The C-terminus of p53: the more you learn the less you know, Nature Struct. Biol., 8, 730, 10.1038/nsb0901-730 · DOI
- Hupp, 1995, Small peptides activate the latent sequence-specific DNA binding function of p53, Cell, 83, 237, 10.1016/0092-8674(95)90165-5 · DOI · Paper page
- Hupp, 1994, Allosteric activation of latent p53 tetramers, Curr. Biol., 4, 865, 10.1016/S0960-9822(00)00195-0 · DOI · Paper page
- Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
- Ayed, 2001, Latent and active p53 are identical in conformation, Nature Struct. Biol., 8, 756, 10.1038/nsb0901-756 · DOI
- Yakovleva, 2001, p53 latency—C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences, J. Biol. Chem., 276, 15650, 10.1074/jbc.M100482200 · DOI
- Kim, 1999, Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53, Oncogene, 18, 7310, 10.1038/sj.onc.1203139 · DOI
- Kim, 1997, DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53, Oncogene, 15, 857, 10.1038/sj.onc.1201412 · DOI
- Kaeser, 2002, Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo, Proc. Natl Acad. Sci. USA, 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
- Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol. Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
- Bayle, 1995, The carboxy-terminal domain of the p53 protein regulates sequence-specific DNA binding through its non-specific nucleic acid-binding activity, Proc. Natl Acad. Sci. USA, 92, 5729, 10.1073/pnas.92.12.5729 · DOI
- Anderson, 1997, Reciprocal interference between the sequence-specific core and non-specific C-terminal DNA binding domains of p53: implications for regulation, Mol. Cell. Biol., 17, 6255, 10.1128/MCB.17.11.6255 · DOI
- LeTilly, 1993, Fluorescence anisotropy assays implicate protein–protein interactions in regulating trp repressor DNA binding, Biochemistry, 32, 7753, 10.1021/bi00081a021 · DOI
- Funk, 1992, A transcriptionally active DNA-binding site for human p53 protein complexes, Mol. Cell. Biol., 12, 2866, 10.1128/MCB.12.6.2866 · DOI · Paper page
- Mujtaba, 2004, Structural mechanism of the bromodomain of the coactivator CP in p53 transcriptional activation, Mol. Cell, 13, 251, 10.1016/S1097-2765(03)00528-8 · DOI · Paper page
- Rustandi, 2000, Structure of the negative regulatory domain of p53 bound to S100B, Nature Struct. Biol., 7, 570, 10.1038/76797 · DOI
- Record, 1991, Analysis of equilibrium and kinetic measurements to determine thermodynamic origins of stability and specificity and mechanism of formation of site-specific complexes between proteins and helical DNA, Methods Enzymol., 208, 291, 10.1016/0076-6879(91)08018-D · DOI · Paper page
- Prives, 2001, Why is p53 acetylated?, Cell, 107, 815, 10.1016/S0092-8674(01)00619-5 · DOI · Paper page
- Barlev, 2001, Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases, Mol. Cell, 8, 1243, 10.1016/S1097-2765(01)00414-2 · DOI · Paper page
- Jiao, 2001, Dynamic interactions of p53 with DNA in solution by time-lapse atomic force microscopy, J. Mol. Biol., 314, 233, 10.1006/jmbi.2001.5129 · DOI
- Midgley, 1992, Analysis of p53 expression in human tumors—an antibody raised against human P53 expressed in Escherichia coli, J. Cell Sci., 101, 183, 10.1242/jcs.101.1.183 · DOI · Paper page
- Miroux, 1996, Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels, J. Mol. Biol., 260, 289, 10.1006/jmbi.1996.0399 · DOI · Paper page
- Neidhardt, 1974, Culture medium for enterobacteria, J. Bacteriol., 119, 736, 10.1128/JB.119.3.736-747.1974 · DOI · Paper page
- Gill, 1989, Calculation of protein extinction coefficients from amino acid sequence data, Anal. Biochem., 182, 319, 10.1016/0003-2697(89)90602-7 · DOI · Paper page
- Johnson, 1994, NMR View - computer program for the visualization and analysis of NMR data, J. Biomol. NMR, 4, 603, 10.1007/BF00404272 · DOI · Paper page
- Hajduk, 1997, NMR-based discovery of lead inhibitors that block DNA binding of the human papilomavirus E2 proein, J. Med. Chem., 40, 3144, 10.1021/jm9703404 · DOI · Paper page
- Weinberg, 2004, Cooperative binding of tetrameric p53 to DNA, J. Mol. Biol., 341, 1145, 10.1016/j.jmb.2004.06.071 · DOI · Paper page
Cited by
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
Structural Biology of the Tumor Suppressor p53
Joerger, A. C., & Fersht, A. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.060806.091238 · Cited by 693
Self-citationXie, H., Vucetic, S., Iakoucheva, L. M., Oldfield, C. J., Dunker, A. K., Uversky, V. N., & Obradovic, Z. (2007) · Journal of Proteome Research · doi:10.1021/pr060392u · Cited by 560
Structure–function–rescue: the diverse nature of common p53 cancer mutants
Joerger, A. C., & Fersht, A. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210291 · Cited by 434
Self-citationThe role of mutant p53 in human cancer
Goh, A. M., Coffill, C. R., & Lane, D. P. (2011) · The Journal of Pathology · doi:10.1002/path.2784 · Cited by 398
Metadata
- Authors
- Weinberg, R. L., Freund, S. M. V., Veprintsev, D. B., Bycroft, M., & Fersht, A. R.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 342
- Issue
- 3
- Pages
- 801-811
- ISSN
- 0022-2836
- Cited by
- 97
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.